These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21951554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical features and prognostic factors in severe cutaneous drug reactions.
    Yang MS, Kang MG, Jung JW, Song WJ, Kang HR, Cho SH, Min KU.
    Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone.
    Natkunarajah J, Goolamali S, Craythorne E, Benton E, Smith C, Morris-Jones R, Wendon J, Higgins E, Creamer D.
    Eur J Dermatol; 2011; 21(3):385-91. PubMed ID: 21527371
    [Abstract] [Full Text] [Related]

  • 9. The DRESS syndrome: the great clinical mimicker.
    Fleming P, Marik PE.
    Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S, Wechsler J, de Feraudy S, Duong TA, Delfau-Larue MH, Chosidow O, Wolkenstein P, Roujeau JC.
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.
    Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V.
    Arch Dermatol; 2009 Jan; 145(1):67-72. PubMed ID: 19153346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY, Lee CK, Choon SE.
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [Abstract] [Full Text] [Related]

  • 17. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP, Paus T, Reichel C, Bieber T, Novak N.
    Eur J Dermatol; 2004 Jul; 14(5):339-42. PubMed ID: 15358574
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
    Lee JY, Lee SY, Hahm JE, Ha JW, Kim CW, Kim SS.
    Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.